ICD-coded information on sites of metastasis in oncology real-world data is specific but not sensitive Published May 2018 Citation Parrinello, C.M., Seidl-Rathkopf, K.N., Bennette, C, Bourla, A.B., Nussbaum, N.C., Carson, K.R., Abernethy, A.P. . ISPOR Annual Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/Sites-of-Mets-Structured-vs-Unstructured-ISPOR-2018-Poster_Vertical_Final_MM.pdf Authors: Sources:ISPOR Annual Meeting Share Posted inPublications More publicationsBlood Cancer JournalDecember 2025Utilization of real-world evidence in regulatory approvals for multiple myeloma therapiesTaylor L, Chen A, Pierre A. Publication summaryPublicationsMultiple myelomaRegulatorySABCSDecember 2025Real-world glucagon-like peptide-1 use and association with clinical characteristics, social determinants, and circulating tumor DNA positivity in patients with breast cancerRyals C, Blarre A, Adamson B, et al.Publication summaryPublicationsBreast cancerSABCSDecember 2025Real-world treatment patterns and clinical outcomes in patients with emerging estrogen receptor 1 (ESR1)-mutated ER+ metastatic breast cancer in the U.S., 2018-2024Meisel J, Pham T, Chen C, Kris A, Roose JPublication summaryPublications